A series of C 1 ‐symmetric phosphine‐phospholane ligands, 1‐(disubstituted phosphino)‐2‐(phospholano)benzenes ( 5 ), which are called UCAPs, with an achiral phosphino group and a chiral phospholane which can be sterically and electrically adjustable, has been designed and synthesized. In the asymmetric hydrogenation of ( Z )‐ N ‐benzoyl‐1‐phenylpropenamine ( 3 ), the stereorecognition abilities of the 5d−e –Rh catalysts which have a bulkier aryl substituent on the achiral phosphorus are superior to that observed with the DuPHOS‐Rh catalyst. The effects of varying substituents on the achiral phosphorus atom are discussed.
No takes yet. Share an insight, caveat, or question.
Matsumura et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: